October 21, 2016 10:10 PM ET


Company Overview of Vertice Pharma, LLC

Executive Profile

Donald W. DeGolyer

Chief Executive Officer and President, Vertice Pharma, LLC
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 9 different industries.

See Board Relationships


Mr. Donald W. DeGolyer, also known as Don, has been Chief Executive Officer of Vertice Pharma, LLC since November 2015 and serves as its President. Mr. DeGolyer served as a Special Advisor to the Chief Executive Officer at Endo International plc (formerly, Endo Health Solutions Inc) from March 2015 to August 1, 2015. Mr. DeGolyer served as the Chief Operating Officer, Pharmaceuticals at Endo Pharmaceuticals Inc. until March Mr. DeGolyer served as the Chief Operating ...

Corporate Headquarters

--, -- --

United Kingdom

Phone: --
Fax: --

Board Members Memberships

Vice Chairman


University of Rochester
Fairleigh Dickinson University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vertice Pharma, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.